Valentina Fossati, Ph.D., of the New York Stem Foundation Research Institute, left, and Andres Bratt-Leal, Ph.D., of Aspen Neuroscience, talk to NASA Social participants during a What’s On Board science briefing at the agency’s Kennedy Space Center in Florida on July 23, 2019. Bratt-Leal and Fossati are principal investigators for the Effects of Microgravity on Microglia 3-Dimensional Models of Parkinson’s Disease and Multiple Sclerosis (Space Tango-Induced Pluripotent Stem Cells) payload.
The briefing was held for SpaceX’s 18th Commercial Resupply Services (CRS-18) mission to the International Space Station. The SpaceX Falcon 9 rocket and uncrewed Dragon spacecraft are scheduled to launch July 24, 2019, from Space Launch Complex 40 at Florida’s Cape Canaveral Air Force Station
Information
Taken in
Kennedy Space Center
作者
NASA/Kim Shiflett
描述
Valentina Fossati, Ph.D., of the New York Stem Foundation Research Institute, left, and Andres Bratt-Leal, Ph.D., of Aspen Neuroscience, talk to NASA Social participants during a What’s On Board science briefing at the agency’s Kennedy Space Center in Florida on July 23, 2019. Bratt-Leal and Fossati are principal investigators for the Effects of Microgravity on Microglia 3-Dimensional Models of Parkinson’s Disease and Multiple Sclerosis (Space Tango-Induced Pluripotent Stem Cells) payload.
The briefing was held for SpaceX’s 18th Commercial Resupply Services (CRS-18) mission to the International Space Station. The SpaceX Falcon 9 rocket and uncrewed Dragon spacecraft are scheduled to launch July 24, 2019, from Space Launch Complex 40 at Florida’s Cape Canaveral Air Force Station